DORMAN PRODUCTS INC (DORM) Fundamental Analysis & Valuation

NASDAQ:DORM • US2582781009

Current stock price

112.18 USD
+0.6 (+0.54%)
Last:

This DORM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. DORM Profitability Analysis

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • DORM had a positive operating cash flow in the past year.
  • In the past 5 years DORM has always been profitable.
  • Each year in the past 5 years DORM had a positive operating cash flow.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • DORM has a better Return On Assets (8.19%) than 88.10% of its industry peers.
  • DORM has a Return On Equity of 13.82%. This is amongst the best in the industry. DORM outperforms 88.10% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.20%, DORM belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DORM is above the industry average of 9.26%.
  • The 3 year average ROIC (11.36%) for DORM is below the current ROIC(13.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROIC 13.2%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 9.59%, DORM belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DORM has remained more or less at the same level.
  • Looking at the Operating Margin, with a value of 16.72%, DORM belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
  • DORM's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 42.14%, DORM belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
  • DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DORM Health Analysis

2.1 Basic Checks

  • DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DORM has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DORM has less shares outstanding
  • The debt/assets ratio for DORM has been reduced compared to a year ago.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • DORM has an Altman-Z score of 4.56. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.56, DORM belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • The Debt to FCF ratio of DORM is 5.81, which is a neutral value as it means it would take DORM, 5.81 years of fcf income to pay off all of its debts.
  • DORM has a Debt to FCF ratio of 5.81. This is in the better half of the industry: DORM outperforms 61.90% of its industry peers.
  • DORM has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.27, DORM is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Altman-Z 4.56
ROIC/WACC1.45
WACC9.13%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that DORM has no problem at all paying its short term obligations.
  • DORM's Current ratio of 3.09 is fine compared to the rest of the industry. DORM outperforms 76.19% of its industry peers.
  • DORM has a Quick Ratio of 1.14. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of DORM (1.14) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 1.14
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DORM Growth Analysis

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.23%, which is quite impressive.
  • Measured over the past years, DORM shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.72% on average per year.
  • The Revenue has been growing slightly by 6.03% in the past year.
  • Measured over the past years, DORM shows a quite strong growth in Revenue. The Revenue has been growing by 14.28% on average per year.
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%

3.2 Future

  • Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 6.46% on average per year.
  • Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 5.64% on average per year.
EPS Next Y-2.7%
EPS Next 2Y2.62%
EPS Next 3Y4.52%
EPS Next 5Y6.46%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. DORM Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.65, DORM is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of DORM indicates a somewhat cheap valuation: DORM is cheaper than 69.05% of the companies listed in the same industry.
  • DORM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.95.
  • Based on the Price/Forward Earnings ratio of 13.00, the valuation of DORM can be described as correct.
  • DORM's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. DORM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.65
Fwd PE 13
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DORM is on the same level as its industry peers.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as DORM.
Industry RankSector Rank
P/FCF 44.6
EV/EBITDA 9.09
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.61
EPS Next 2Y2.62%
EPS Next 3Y4.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DORM Dividend Analysis

5.1 Amount

  • No dividends for DORM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORM Fundamentals: All Metrics, Ratios and Statistics

DORMAN PRODUCTS INC

NASDAQ:DORM (4/21/2026, 10:43:04 AM)

112.18

+0.6 (+0.54%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners90.37%
Inst Owner Change0.15%
Ins Owners12.82%
Ins Owner Change2.74%
Market Cap3.37B
Revenue(TTM)2.13B
Net Income(TTM)204.19M
Analysts85.71
Price Target156.44 (39.45%)
Short Float %4.63%
Short Ratio4.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.11%
Min EPS beat(2)-0.69%
Max EPS beat(2)2.92%
EPS beat(4)3
Avg EPS beat(4)12.48%
Min EPS beat(4)-0.69%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)22.38%
EPS beat(12)8
Avg EPS beat(12)10.5%
EPS beat(16)9
Avg EPS beat(16)7.26%
Revenue beat(2)0
Avg Revenue beat(2)-5.69%
Min Revenue beat(2)-8.11%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)-9.98%
PT rev (3m)-11.6%
EPS NQ rev (1m)-0.09%
EPS NQ rev (3m)-23.28%
EPS NY rev (1m)-3.62%
EPS NY rev (3m)-10.42%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 12.65
Fwd PE 13
P/S 1.58
P/FCF 44.6
P/OCF 29.7
P/B 2.28
P/tB 4.05
EV/EBITDA 9.09
EPS(TTM)8.87
EY7.91%
EPS(NY)8.63
Fwd EY7.69%
FCF(TTM)2.52
FCFY2.24%
OCF(TTM)3.78
OCFY3.37%
SpS70.82
BVpS49.1
TBVpS27.68
PEG (NY)N/A
PEG (5Y)0.61
Graham Number98.9955 (-11.75%)
Profitability
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROCE 17.81%
ROIC 13.2%
ROICexc 13.54%
ROICexgc 20.22%
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
FCFM 3.55%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
ROICexc(3y)11.65%
ROICexc(5y)10.5%
ROICexgc(3y)18.73%
ROICexgc(5y)16.69%
ROCE(3y)15.58%
ROCE(5y)14.81%
ROICexgc growth 3Y20.29%
ROICexgc growth 5Y5.06%
ROICexc growth 3Y25.64%
ROICexc growth 5Y0.33%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
F-Score8
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Debt/EBITDA 0.98
Cap/Depr 68.13%
Cap/Sales 1.78%
Interest Coverage 13.02
Cash Conversion 27.58%
Profit Quality 37.06%
Current Ratio 3.09
Quick Ratio 1.14
Altman-Z 4.56
F-Score8
WACC9.13%
ROIC/WACC1.45
Cap/Depr(3y)72.66%
Cap/Depr(5y)71.81%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.94%
Profit Quality(3y)88.47%
Profit Quality(5y)65.95%
High Growth Momentum
Growth
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
EPS Next Y-2.7%
EPS Next 2Y2.62%
EPS Next 3Y4.52%
EPS Next 5Y6.46%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%
EBIT growth 1Y21.63%
EBIT growth 3Y27.72%
EBIT growth 5Y21.71%
EBIT Next Year11.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.51%
FCF growth 3Y171.04%
FCF growth 5Y-11.13%
OCF growth 1Y-50.82%
OCF growth 3Y39.68%
OCF growth 5Y-5.65%

DORMAN PRODUCTS INC / DORM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 5 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


How profitable is DORMAN PRODUCTS INC (DORM) stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


What is the financial health of DORMAN PRODUCTS INC (DORM) stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 7 / 10.


What is the earnings growth outlook for DORMAN PRODUCTS INC?

The Earnings per Share (EPS) of DORMAN PRODUCTS INC (DORM) is expected to decline by -2.7% in the next year.